The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
Recurrent disease and treatment-associated chemoresistance are the two main factors accounting for poor clinical outcomes of ovarian cancer (OC) patients. Both can be associated with cancer stem cells (CSCs), which contribute to cancer formation, progression, chemoresistance, and recurrence. Hence,...
Main Authors: | Natalia Izycka, Marcin Rucinski, Malgorzata Andrzejewska, Sebastian Szubert, Ewa Nowak-Markwitz, Karolina Sterzynska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/3/2400 |
Similar Items
-
The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer
by: Peng Jiang, et al.
Published: (2024-04-01) -
Low CD8<sup>+</sup> T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44<sup>+</sup>/CD133<sup>+</sup> Cancer Stem Cells and Predict an Unfavorable Prognosis in Pancreatic Cancer
by: Ya-Chin Hou, et al.
Published: (2019-04-01) -
FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
by: A. B. Sagakyants, et al.
Published: (2021-03-01) -
Prostate Cancer Stem Cells: The Role of CD133
by: Jianhui Yang, et al.
Published: (2022-11-01) -
CD44 Expression Intensity Marks Colorectal Cancer Cell Subpopulations with Different Extracellular Vesicle Release Capacity
by: Andrea Kelemen, et al.
Published: (2022-02-01)